|
|
|
|---|---|
|
January
January; Goals of effective platelet inhibition |
March
March; The Emerging Concept of Global Cardiometabolic Risk |
|
April
April; Fondaparinux: a new standard of care in acute coronary syndromes and beyond |
May
May; Emerging Issues and New Pharmacologic Options for P2Y12 Inhibition in Acute Coronary Syndromes |
|
July
July; Hot Topics in Aortic Stenosis |
|